BeStock  
Stocks › Biotechnology › BBIO

BridgeBio Pharma BBIO

US equityMarket cap rank #1114Biotechnology
$76.03 −$2.15 (-2.75%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $76.03 0.00%
Open$77.85
Prev close$78.18
Day range$75.46 – $78.24
Volume1.48M
Market cap$14.81B
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±3.8%last 8 reports
Closed higher3 of 838% of the time
Best reaction+6.0%
Worst reaction-8.9%

Stock move on the day after each report

+1.4%2024/Q4+5.3%2025/Q1-8.9%2025/Q2-4.9%2025/Q3-2.6%2025/Q4-0.1%2026/Q1-1.1%2026/Q2+6.0%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q329 Oct 2026After Market±10.2%+5.97%Within range
2026/Q210 Aug 2026After Market±7.2%-1.15%Within range
2026/Q17 May 2026After Market±7.2%-0.09%Within range
2025/Q424 Feb 2026After Market±11.0%-2.59%Within range
2025/Q329 Oct 2025After Market±10.9%-4.88%Within range
2025/Q25 Aug 2025After Market±14.5%-8.94%Within range
2025/Q129 Apr 2025After Market±12.9%+5.33%Within range
2024/Q420 Feb 2025Pre Market±14.7%+1.42%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$353.17M+192.6% YoY
Operating profit-$11.64M+91.5% YoY
Net profit-$60.50M+67.3% YoY
Diluted EPS-$0.42+55.8% YoY
Free cash flow-$44.46M+60.5% YoY
Operating cash flow-$44.17M

Revenue, last 8 quarters

$5.9MDec '24$116.6MMar '25$110.6MJun '25$120.7MSep '25$154.2MDec '25$194.5MMar '26$243.7MJun '26$353.2MSep '26

Net profit, last 8 quarters

$-267.4MDec '24$-169.6MMar '25$-183.8MJun '25$-184.9MSep '25$-194.6MDec '25$-166.6MMar '26$-155.9MJun '26$-60.5MSep '26

Profitability & balance sheet

Gross margin94.3%
Operating margin-37.3%
Net margin-62.6%
Return on assets-37.5%
Current ratio2.09
Liabilities / assets176.5%
Cash & investments$1.54B
Total debt$2.49B
Net cash (debt)-$953.20M

Discussion

No comments yet — be the first to weigh in on BBIO.

Sign in to join the discussion.

Scroll to Top